Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H ( (HK:1558) ) is now available.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has announced its 2025 Annual General Meeting (AGM) scheduled for May 29, 2025, in Dongguan, Guangdong Province, China. The AGM will address several resolutions, including the approval of the 2024 annual financial reports and the re-appointment of KPMG as the company’s auditor. This meeting is significant for stakeholders as it will determine the company’s financial and operational strategies for the upcoming year.
More about YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. It focuses on the development, production, and sale of pharmaceutical products.
YTD Price Performance: 27.62%
Average Trading Volume: 5,076,462
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$10.74B
Find detailed analytics on 1558 stock on TipRanks’ Stock Analysis page.